Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia

Br J Haematol. 2021 Dec;195(5):703-705. doi: 10.1111/bjh.17813. Epub 2021 Aug 31.
No abstract available

Keywords: ITP; SARS-CoV; vaccines.

Publication types

  • Letter
  • Observational Study

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273 / administration & dosage
  • 2019-nCoV Vaccine mRNA-1273 / adverse effects
  • Adult
  • Aged
  • Aged, 80 and over
  • BNT162 Vaccine / administration & dosage
  • BNT162 Vaccine / adverse effects*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • ChAdOx1 nCoV-19 / administration & dosage
  • ChAdOx1 nCoV-19 / adverse effects
  • Female
  • Follow-Up Studies
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Platelet Count / standards
  • Prospective Studies
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic / epidemiology
  • Purpura, Thrombocytopenic, Idiopathic / etiology*
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / immunology
  • Safety

Substances

  • ChAdOx1 nCoV-19
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine